Market Place
Sourcing Support
Zai Lab & Pfizer Announce Collaboration on Antibacterial Drug
21 Nov 2024 //
BUSINESSWIRE
Enforcement Report - Week of May 24, 2023
24 May 2023 //
FDA
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO
23 May 2023 //
BUSINESSWIRE
Pfizer halts 4 antibiotics in India due to production issues
19 May 2023 //
FIERCE PHARMA
Results from Phase 3 ATTACK Trial Published in The Lancet Infectious Diseases
11 May 2023 //
BUSINESSWIRE
FDA panel backs Innoviva`s drug for multidrug-resistant bacterial infections
18 Apr 2023 //
REUTERS
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA
17 Apr 2023 //
BUSINESSWIRE
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Innoviva Announces FDA Acceptance and Priority Review of NDA for (SUL-DUR)
30 Nov 2022 //
BUSINESSWIRE
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
19 Aug 2022 //
PRNEWSWIRE
Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM
09 Jun 2022 //
GLOBENEWSWIRE
Entasis antibiotic beats last resort treatment in phase 3 trial
20 Oct 2021 //
YAHOOFINANCE
Entasis Therapeutics Readies $75 Million IPO Plan
20 Sep 2018 //
SEEKING ALPHA
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Enforcement Report - Week of February 14, 2018
14 Feb 2018 //
FDA
AuroMedics’ double take: Glass in vials prompts another recall in US
05 Jan 2018 //
IN PHARMATECHNOLOGIST
Mylan Launches Generic Unasyn® for Injection
14 Sep 2015 //
PR NEWS WIRE
IMA to Come Out With Uniform Guidelines On Rational Use Of Drugs To Tackle Antibiotic Resistance, ADRs
11 Dec 2014 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.